CYNOSURE, INC. Inactive Instrument
Company Cynosure, Inc.
Equities
US2325772059
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Nadav Tomer
CEO | Chief Executive Officer | - | 23-04-30 |
Jim Palastra
COO | Chief Operating Officer | - | - |
James Boll
CTO | Chief Tech/Sci/R&D Officer | - | 92-12-31 |
Pamela Baxter
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-31 |
Kibbey Lowinn
PRN | Corporate Officer/Principal | - | - |
Erik Glaser
PRN | Corporate Officer/Principal | - | - |
Sean Flanagan
LAW | General Counsel | - | 18-09-30 |
Jorge Pinedo
PRN | Corporate Officer/Principal | - | - |
Sonal Patel
PRN | Corporate Officer/Principal | - | - |
Maureen Tarca
HRO | Human Resources Officer | - | 04-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sandra Peterson
CHM | Chairman | 65 | 19-11-30 |
Michael Davin
CEO | Chief Executive Officer | 66 | 03-08-31 |
Derek Strum
BRD | Director/Board Member | 46 | 19-11-30 |
Anne Gates
BRD | Director/Board Member | 64 | - |
Michelle Freyre
BRD | Director/Board Member | - | 20-01-21 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 25,316,000 | 22,699,180 ( 89.66 %) | 1,628,000 ( 6.431 %) | 89.66 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +8.37% | 219B | |
| +6.37% | 183B | |
| +10.64% | 133B | |
| +24.86% | 108B | |
| +0.27% | 63.06B | |
| +12.01% | 52.02B | |
| +3.96% | 48.2B | |
| -0.04% | 40.37B | |
| +14.67% | 39.35B |
- Stock Market
- Equities
- Stock
- Company Cynosure, Inc.
